Search hospitals > Pennsylvania > State College
Geisinger Medical Group
Claim this profileState College, Pennsylvania 16801
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Non-Small Cell Lung Cancer
190 reported clinical trials
11 medical researchers
Summary
Geisinger Medical Group is a medical facility located in State College, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Geisinger Medical Group is involved with conducting 190 clinical trials across 325 conditions. There are 11 research doctors associated with this hospital, such as Raghava Reddy Levaka Veera, Joseph J. Vadakara, Sorab Gupta, and Namita Sharma.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Raghava Reddy Levaka VeeraGeisinger Wyoming Valley/Henry Cancer Center5 years of reported clinical research
Expert in Cancer
Studies Adenocarcinoma
19 reported clinical trials
43 drugs studied
Joseph J. VadakaraGeisinger Medical Center5 years of reported clinical research
Studies Leukemia
Studies Lymphoma
21 reported clinical trials
69 drugs studied
Sorab GuptaGeisinger Medical Center3 years of reported clinical research
Studies Cancer
Studies Squamous Cell Carcinoma
13 reported clinical trials
24 drugs studied
Namita SharmaGeisinger Wyoming Valley/Henry Cancer Center4 years of reported clinical research
Studies Cancer
Studies Breast Cancer
11 reported clinical trials
29 drugs studied
Clinical Trials running at Geisinger Medical Group
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Cancer
Cancer
Meningioma
Multiple Myeloma
Squamous Cell Carcinoma
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
Chemotherapy Reduction After Surgery
for Breast Cancer
This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab and pertuzumab are both a form of "targeted therapy" because they work by attaching themselves to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When these drugs attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving paclitaxel, trastuzumab, and pertuzumab may enable fewer chemotherapy drugs to be given without compromising patient outcomes compared to the usual treatment.
Recruiting1 award Phase 227 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Geisinger Medical Group?
Geisinger Medical Group is a medical facility located in State College, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Geisinger Medical Group is involved with conducting 190 clinical trials across 325 conditions. There are 11 research doctors associated with this hospital, such as Raghava Reddy Levaka Veera, Joseph J. Vadakara, Sorab Gupta, and Namita Sharma.